A recent 13% uptick in the value of Tilray stock prevailed over a Forbes article from August 15th on how they feel that “…Cannabis Producer Tilray Is Currently Overvalued”. The Forbes article prices the stock at a $25 price estimate derived from the estimates of Tilray’s revenue projections for 2018.

Tilray stock continued and prevailed and increased an additional 13% on August 31st even with concerns for Tilray’s potential bubble bursting. The latest information from Forbes on the issue is that the company’s increase is “…disconnected from its near-term growth prospects.”

Leave a Reply